Company · Healthtech & Bio

Ideeea Therapeutics

ideatx.com ↗ ·Madrid ·Seed

Ideeea Therapeutics (branded 'ideatx') is a Madrid-based biotech developing and manufacturing Advanced Therapy Medicinal Products (ATMPs) — allogeneic cell, gene and tissue-engineered therapies for regenerative and autoimmune medicine — covering the full value chain from R&D to GMP manufacturing. It was founded by healthcare executives from the Spanish pharma group FARMALIDER and its lead preclinical program is AGAcell®, an intradermal mesenchymal stem-cell formulation for androgenetic alopecia. The company raised a ~€2.3M seed round backed by private investors and Spain's CDTI under the EU NextGeneration/PERTE program.

Founded

2020

Founders

News

Rounds

Investors

SectorsBiotech, Cell & Gene Therapy, Advanced Therapy Medicinal Products (ATMPs), Regenerative Medicine, Pharma Start-up MapHealthtech & Bio › Drug discovery & therapeutics developers

Profile updated 31 Aug 2026

Founders

José Ángel Sánchez García

Chief Innovation Officer & Co-Founder

—

Marisa Berenguer Muñoz

CEO & Co-Founder

—

Global models

No comparables on record yet.

Investors 2

CDTI (Centro para el Desarrollo Tecnológico y la Innovación)

www.cdti.es

Investor Spain

Farmalider

farmalider.com ↗

Investor Spain

Funding rounds 1

Seed · €2.3M

Advanced-therapy biotech Ideeea Therapeutics closed a €2.3M seed round backed by private investors and CDTI under the PERTE for Cutting-Edge…

2025-06-03

News & media 3

Published	Article
2025-11-21	ASEME reconoce a Marisa Berenguer por su proyecto biotecnológico contra la alopecia ↗ Pharmatech
2025-08-10	Ideeea Therapeutics AGAcell: MSCs and ATP ↗ Hair Loss Cure 2020
2025-07-10	Top 10 Startups – July 25 ↗ TSCFO